1. Annual report 2024
  2. Research
  3. ECONSAP

ECONSAP

Research Group on Health Economics in Primary Care

Ours is a multidisciplinary group made up of 14 researchers, four family doctors (two of them doctors and one doctoral student), two Primary Care (PC) nurses, a primary care paediatrician, three doctors in Psychology, three doctors in Pharmacy and a doctor in Psychiatry. They are researchers from different fields and specialties who participate in projects related to the field of mental health (epidemiology, drug consumption, analysis of the effectiveness and cost-effectiveness of treatments, evaluation of effectiveness and therapeutic cost-effectiveness evaluated both quantitatively and qualitatively), evaluation of new interventions to address chronic pain, improvement in the quality of life of patients with mental disorders and chronic diseases such as fibromyalgia and chronic pain and both quantitative and qualitative evaluation of adherence to drugs prescribed by PC.

This last line is one of the most active in recent years, with studies focused on non-initiation and others focused on the consumption of psychotropic drugs (antipsychotics, benzodiazepines).

In recent years, the group has become increasingly specialized in the economic evaluation of health in PC, making this line of research the transversal axis of almost all the projects we lead or in which we participate.

In order to comprehensively understand the management of pathologies in primary care and the efficiency of treatments, as well as to identify facilitators and barriers, the group complements the use of clinical trials and economic evaluations with other designs, such as qualitative research, systematic reviews, and epidemiological studies based on large databases,  such as SIDIAP or PADRIS, all within the framework of research in the field of primary care.

Group projects

  • Recerca en Economia de la Salut a l'Atenció Primària ECONSAP. (INTENS-23/7). ICS - Institut Català de la Salut. 2024-2026. IP: Mª Teresa Peñarrubia María.
  • Desenvolupament del rol investigador en infermeria mitjançant dues línies de recerca del grup Economía de la Salut a l?Atenció Primària. ICS - Institut Català de la Salut. 2023-2024. IP: Maria del Carmen Gallardo González.
  • Recerca en Economia de la Salut a l?Atenció Primària. ICS - Institut Català de la Salut. 2022-2024. IP: Mª Teresa Peñarrubia María.
  • Estudi pilot sobre l'aplicació d'un programa docent sobre el model comunicacional de presa de decisions compartides a la consulta per a metges/ses residents/es de medicina familiar i comunitària. (C_Novartis-20/3). 2020-2024. IP: Sara-Anna Davies Daunas.
  • Motivaciones en la cronificación del Uso de Benzodiacepinas: Un estudio cualitativo. 2024-2025. Financiado por MAGIC LINE (PFNR0207). Presupuesto: 9.000€. IP: Mª Teresa Peñarrubia María. IC: Mª Carmen Olmos Palenzuela, Lucy Anne Parker e Ignacio Aznar Lou.
  • The impact of the COVID-19 pandemic and its restrictions on chronification of benzodiazepine use. Consoricio Centro de Investigación Biomédica en RED (CIBER); Fundació per a la recerca i la Docència Sant Joan de Déu. 2022-2025. IP: Ignacio Aznar Lou.
  • Avaluació de l'efectivitat i cost-efectivitat de la intervenció d'Adherència Inicial a la Medicació (IMA): Assaig controlat aleatoritzat per conglomerats i model econòmic (IMA-cRCT). European Commission. 2021-2024. IP: Maria Rubio Valera.
  • Developing, implementing and evaluating a clinical care pathway for NASH primary care patients: a multi-centre study. Gilead Sciences, S.L. 2020-2025. IP: Juan Manuel Mendive Arbeloa.

Group publications

  • Aznar Lou I, Peñarrubia Maria M, Parker L. Chronification in the use of benzodiacepines: incidence stratified by sex and age groups. Value Health. 2023;26(12):538-538.
  • Sánchez Viñas A, Corral Partearroyo C, Gil Girbau M, Penarrubia Maria MT, Gallardo Gonzalez C, Olmos Palenzuela M et al. Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study) (vol 23, 170, 2022). BMC Prim Care. 2024;25(1):437-437. PMID:39731006.
  • Evers S, Kenkre J, Kloppe T, Kurpas D, Mendive JM, Petrazzuoli F et al. Survey of general practitioners' awareness, practice and perception of social prescribing across Europe. Eur J Gen Pract. 2024;30(1):2351806-2351806. PMID:38757217.
  • Ibáñez D, Condominas E, Haro JM, Vázquez IG, R, Bailón R et al. Pre- and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study. Front. Psychol. 2024;151436611-1436611. PMID:39606213.
  • Muhl C, Mulligan K, Giurca BC, Polley MJ, Bloch G, Nowak DA et al. Building common understanding: seeking consensus and defining social prescribing across contexts - a collective commentary on a Delphi study. BMC Health Serv. Res. 2024;24(1):PMID:39449029.
  • Lionis C, Papadakis S, Anastasaki M, Aligizakis E, Anastasiou F, Francque S et al. Practice Recommendations for the Management of MASLD in Primary Care: Consensus Results. Diseases. 2024;12(8):PMID:39195179.
  • Kahrilas P, Anastasiou F, Bredenoord AJ, El Serag HB, Labenz J, Mendive J et al. Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop. Dig. Dis. 2024;42(3):211-220. PMID:38513623.
  • Krznaric Z, Bender DV, Kovac MB, Cuerda C, Ginkel Res AV, Hiesmayr M et al. Clinical nutrition in primary care: ESPEN position paper. Clin Nutr. 2024;43(6):1678-1683. PMID:38471980.
  • Kahrilas PJ, Anastasiou F, Barrett K, Beh L, Chinzon D, Doerfler B et al. Assessment and treatment of refluxlike symptoms in the community: a multidisciplinary perspective. Br. J. Gen. Pract. 2024;74(742):232-235. PMID:38664044.
  • Puig Molto M, Lumbreras B, Mendive JM, Lopez Pintor E. Impact of a pharmaceutical algorithm on patients with upper-gastrointestinal symptoms: A pre-post intervention study. Prev Med. 2024;180107885-107885. PMID:38316273.
  • Hungin AP, Yadlapati R, Anastasiou F, Bredenoord AJ, El Serag H, Fracasso P et al. Management advice for patients with reflux-like symptoms: an evidence-based consensus. Eur. J. Gastroenterol. Hepatol. 2024;36(1):13-25. PMID:38006602.
Anar a l'inici